Airing weekdays at 7:30 A.M. on

Airing weekdays at 7:30 A.M. on

Novocure®, a global oncology company, is working to extend survival in some of the most aggressive forms of cancer by developing and commercializing its innovative therapy, tumor treating fields.

Learning more about two diseases that affect the brain: glioblastoma and schizophrenia.

Knowing the risk of being an OTC carrier and how to prepare for it with the UCD Genetic Testing Program, sponsored by Horizon Therapeutics and performed by Invitae.

Acromegaly is a slow-progressing disorder that occurs when the pituitary gland produces too much growth hormone.

Up next, stay tuned for a brand-new Behind the Mystery special — only on The Balancing Act.

Glioblastoma (GBM) is rare brain tumor that is difficult to treat and has a poor prognosis.

Clinical trials are an opportunity for patients to receive promising new therapies, but they can be difficult to navigate. Learn how The Leukemia & Lymphoma Society’s Clinical Trial Support Center is helping guide patients.

There are approximately 7,000 known rare diseases, but only 5% of them have an approved treatment. Learn how early intervention, proper management strategies, and clinical trials are key for rare disease patients. 

Friedreich’s Ataxia is a progressive and debilitating neurological disorder. It's important to recognize symptoms and obtain an early diagnosis to properly manage the condition.